Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net income (loss) $ (476) $ 499
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 753 699
Share-based compensation expense 91 84
Non-cash interest expense 16 43
Amortization of debt issuance costs, premium and discount 57 94
Reduction of right-of-use assets 269 222
Loss on modification or extinguishment of debt 95 215
Total losses (gains) on derivatives, net 4,230 (282)
Net cash provided by (used for) settlement of derivative instruments (486) 61
Impairment expense and loss on disposal of assets 0 5
Impairment expense and loss on equity method investments 16 130
Deferred taxes (1,872) 115
Repayment of paid-in-kind interest related to repurchase of convertible notes (190) (911)
Other 3 2
Changes in operating assets and liabilities:    
Accounts and other receivables, net of current expected credit losses (338) 101
Inventory (174) 31
Margin deposits (311) (10)
Other current assets (92) (27)
Accounts payable and accrued liabilities 612 (93)
Deferred revenue 58 18
Operating lease liabilities (285) (205)
Finance lease liabilities 1 0
Other, net 80 (26)
Net cash provided by operating activities 2,057 765
Cash flows from investing activities    
Property, plant and equipment (761) (1,437)
Proceeds from sale of fixed assets 68 0
Investment in equity method investment 0 (100)
Other (14) (8)
Net cash used in investing activities (707) (1,545)
Cash flows from financing activities    
Proceeds from issuances of debt 4,104 7,683
Repayments of debt (4,276) (6,324)
Debt issuance and other financing costs (38) (124)
Debt modification or extinguishment costs (67) (170)
Distributions to non-controlling interest (483) (468)
Payments related to tax withholdings for share-based compensation (47) (43)
Repurchase of common stock (6) (155)
Other 8 0
Net cash provided by (used in) financing activities (805) 399
Net increase (decrease) in cash, cash equivalents and restricted cash 545 (381)
Cash, cash equivalents and restricted cash—beginning of period 2,077 2,994
Cash, cash equivalents and restricted cash—end of period $ 2,622 $ 2,613